Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Future PC-SPES research

This article was originally published in The Tan Sheet

Executive Summary

UCLA's Center for Human Nutrition is working with PC-SPES inventor Sophie Chen to ensure future research of the recalled herbal blend, according to UCLA Division of Clinical Nutrition Director David Heber, MD/PhD. "The strategies and details for manufacturing enough material for the ongoing...clinical trials in a properly controlled manufacturing environment are being actively developed," Heber noted during a House Government Reform Committee hearing July 25. PC-SPES was recalled in February due to contamination with warfarin, but Heber and colleagues believe the herbal mixture may inhibit cancer cell growth. Separately, the UCLA researcher filed an IND with FDA in mid-June to conduct metabolic studies comparing red yeast rice and Merck's cholesterol-lowering drug Mevacor...

Related Content

PC-SPES research





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts